Larry Beresford is a freelance medical journalist in Oakland, Calif.
Editor’s note: The ACR recently released a white paper on biosimilars.
The FDA Approved Several New Rheumatology Drugs in 2017
• By Larry Beresford
- Tweet
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
You Might Also Like:
- Etanercept Biosimilar Approved in EU, Plus FDA Reviews Brodalumab for Plaque Psoriasis
- First Biosimilar Drugs Approved in U.S., Canada
- The ACR Addresses the FDA about the Safe Adoption of Biosimilars in the U.S.; Plus Tofacitinib Approved for RA & Romosozumab May Reduce Fracture Risk
- FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review